Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-26-044969
Filing Date
2026-04-17
Accepted
2026-04-17 17:13:33
Documents
12
Period of Report
2026-04-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K/A ibio-20260408x8ka.htm   iXBRL 8-K/A 31312
  Complete submission text file 0001104659-26-044969.txt   151216

Data Files

Seq Description Document Type Size
2 EX-101.SCH ibio-20260408.xsd EX-101.SCH 3502
3 EX-101.DEF ibio-20260408_def.xml EX-101.DEF 2848
4 EX-101.LAB ibio-20260408_lab.xml EX-101.LAB 17254
5 EX-101.PRE ibio-20260408_pre.xml EX-101.PRE 11362
15 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20260408x8ka_htm.xml XML 4808
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-35023 | Film No.: 26872604
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)